Intercell Biomedical appoints site director
pharmafile | October 6, 2010 | Appointment | Manufacturing and Production, Research and Development |Â Â Intercell, appointment, research and developmentÂ
Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.
He joins the firm from Novartis Vaccines, where he held a wide range of positions of increasing responsibility at its Marburg, Germany facility.
Prior to his time with Novartis Eric served at Chiron Vaccines.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






